clinical lung cancer

Pulmonary and Respiratory Medicine

Clinical Lung Cancer

Editor in Chief: David Gandara, MD

Clinical Lung Cancer is a peer-reviewed bi-monthly journal established in 1999. It features an international editorial board comprised of prominent thought leaders, including Editor-in-Chief Dr. David Gandara. It is mailed free of charge to US-based medical oncologists, hematologists, radiation oncologists and surgical oncologists. Each issue features peer-reviewed original contributions, invited comprehensive reviews and current treatment reports, commentaries, clinical trial lists, as well as meeting highlights taken from major oncology meetings throughout the year. Also included are brief editorials of current news and the latest topics concerning lung cancer issues relevant to clinicians.

Global Print Circulation
9,506
Avg. Global Monthly Visits
9,602
Avg. Global Monthly Unique Visitors
7,171
Avg. Global Monthly Page Views
14,768
Avg. Global eTOC Distribution
12,248
Circulation updated on 1st July, 2024, based on 12-month monthly average July 2023-June 2024, eTOC Metrics: 12 Month Average of eTOC sends - July 2023 to June 2024, Monthly average web metrics based on the period of July 2023 to June 2024

Rate Card

Find the best value for your advertising dollars

Journal Website

Find out more directly from the source

Journal Metrics

Detailed insights into the reach and penetration of this journal

Contacts

Elsevier

Circle Placeholder
Elsevier Inbound Sales

Email : journalmedia@elsevier.com